New Zealand industry healthy and with a bright future
This article was originally published in Clinica
New Zealand’s 89 small-to-medium medical device companies earn the country around NZ$550m (US$281m) per year (NZ$554m in 2007-08) and employ around 3,000 people in total. And according to “The New Zealand Medical Technologies Sector Overview”, which was commissioned by the country’s biotechnology association NZBio, direct, indirect and induced income from the sector contributes around NZ$1.1bn to the local economy, which is expected to increase to NZ$2.95bn in three to five years.
You may also be interested in...
Three upcoming medical device regulations were discussed at BSI’s Hong Kong Forum in April that will be important to the success of Hong Kong’s voluntary regulatory system, the Medical Device Administrative Control System.
Saudi Arabia has adopted an interim marketing authorisation regulation under which, possibly as early as 2010, only medical devices that have been approved by the Saudi Arabia Food and Drug Administration will be allowed on the market1. Additionally, only medical devices that comply with the regulations in force in the European Union, the US, Canada, Japan or Australia – ie in the jurisdiction of a Global Harmonization Task Force founding member - will be eligible for marketing in the country2,3.
The government of Canada has launched a marketing campaign to encourage consumers and healthcare professionals to use the country’s MedEffect initiative for reporting suspected adverse events related to healthcare products1.